first_img “This Stock Could Be Like Buying Amazon in 1997” Cliff D’Arcy | Tuesday, 8th December, 2020 | More on: BATS BP GSK Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! Enter Your Email Address When I view the FTSE 100 chart for 2020, I call it ‘the Big W’. From March, the Footsie lurched south, tracing the W’s first downward stroke. An upward stroke was drawn from March’s lows to early June. Then came a decline until Halloween, followed by a rebound last month. November’s bumper rebound — the FTSE 100 rose by (12.4%) — was the index’s second-best month in 36 years. But several cheap shares have been left behind in 2020 — and I still see value in some stocks.The FTSE 100’s 30% comebackThe FTSE 100 hit its 2020 closing high on 17 January, peaking at 7,674.6 points. As Covid-19 spread, the index collapsed, crashing to close at 4,993.9 on 23 March. That’s a fall of more than a third (34.9%) in two months. Today, the Footsie hovers around 6,521.48, up more than 30% since this market meltdown. But many cheap shares have gone nowhere for ages — and some stocks keep falling.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…Within the FTSE 100, I found that 76 of these stocks gained over the past six months. The highest increase was 62% and the lowest a mere 0.1%. Across these 76 gainers, the average rise was 17.1%. However, 24 stocks lost value over this period. The biggest loss was 20.5% and the smallest was 0.5%. The average decrease across all 24 fallers was 8.4%. Today, I’ve been bottom-fishing among these 24 cheap shares.These cheap shares miss outAmong the FTSE 100’s 10 worst performers over six months are three cheap shares that missed the rising tide. These great British businesses are British American Tobacco (LSE: BATS), down 8.8% in six months, GlaxoSmithKline (LSE: GSK), down 15.3% and BP (LSE: BP) down 20.5%. I’ve written about these three value stocks repeatedly in recent months. When I began this article, I set out to avoid mentioning any of these Goliaths. Yet fundamentals once again push me in the direction of deep-value stocks primed to rebound in 2021.Two of these three cheap shares are no-go stocks for ethical and green investors. BATS is the world’s second-largest cigarette manufacturer, so its dividend yield of 7.4% a year is banned for ethical investors. Likewise, as one of the world’s energy behemoths and a global polluter, BP is vetoed by environmental investors. Yet its colossal dividend also helps to underpin the FTSE 100’s income yield.GSK is ready to rebound in 2021For the record, GSK is one of my favourite cheap shares. Currently, it’s the only listed stock I directly hold in my own name. I’ve been a GSK shareholder for most of the past 30 years, watching its ups and downs since the late 80s. Right now, I think GSK is about as overlooked, unloved, unwanted and undervalued as at any point in this millennium.I stick with GSK because it’s what I call an SLR share. It offers Safety (it’s a £70.1bn giant), Liquidity (it’s a highly liquid, easily traded stock) and Returns (its solid dividends attract me). Today, the GSK share price stands just below 1,388p. This puts its shares on a price-to-earnings ratio of 11 and an earnings yield of 9.1%. The 80p-a-share yearly dividend equates to a dividend yield of over 5.7%. That’s almost twice the FTSE 100’s dividend yield — and it’s why I keep buying GSK shares hoping for a potential 2021 recovery! I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Cliffdarcy owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. The FTSE 100 is up over 30% since March, but I’d buy these cheap shares for a 2021 rebound!center_img Image source: Getty Images. Our 6 ‘Best Buys Now’ Shares I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. Simply click below to discover how you can take advantage of this. See all posts by Cliff D’Arcylast_img